Actinium Pharmaceuticals Inc (ATNM)
8.96
+0.21
(+2.40%)
USD |
NYAM |
May 03, 16:00
8.915
-0.04
(-0.50%)
After-Hours: 20:00
Actinium Pharmaceuticals Total Liabilities (Quarterly): 44.50M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 44.50M |
| December 31, 2023 | 45.07M |
| September 30, 2023 | 45.36M |
| June 30, 2023 | 45.97M |
| March 31, 2023 | 44.82M |
| December 31, 2022 | 47.71M |
| September 30, 2022 | 45.56M |
| June 30, 2022 | 43.62M |
| March 31, 2022 | 5.725M |
| December 31, 2021 | 6.843M |
| September 30, 2021 | 4.194M |
| June 30, 2021 | 3.955M |
| March 31, 2021 | 4.361M |
| December 31, 2020 | 5.078M |
| September 30, 2020 | 5.10M |
| June 30, 2020 | 5.184M |
| March 31, 2020 | 5.344M |
| December 31, 2019 | 6.026M |
| September 30, 2019 | 6.382M |
| June 30, 2019 | 6.118M |
| March 31, 2019 | 6.892M |
| December 31, 2018 | 6.077M |
| September 30, 2018 | 4.122M |
| June 30, 2018 | 5.266M |
| March 31, 2018 | 6.393M |
| Date | Value |
|---|---|
| December 31, 2017 | 4.666M |
| September 30, 2017 | 3.529M |
| June 30, 2017 | 4.106M |
| March 31, 2017 | 5.370M |
| December 31, 2016 | 4.521M |
| September 30, 2016 | 3.028M |
| June 30, 2016 | 2.488M |
| March 31, 2016 | 3.286M |
| December 31, 2015 | 4.614M |
| September 30, 2015 | 2.155M |
| June 30, 2015 | 3.051M |
| March 31, 2015 | 3.611M |
| December 31, 2014 | 9.492M |
| September 30, 2014 | 10.23M |
| June 30, 2014 | 11.12M |
| March 31, 2014 | 20.03M |
| December 31, 2013 | 7.325M |
| September 30, 2013 | 3.446M |
| June 30, 2013 | 3.820M |
| March 31, 2013 | 2.806M |
| December 31, 2012 | 4.643M |
| September 30, 2012 | 0.104M |
| June 30, 2012 | 0.1004M |
| March 31, 2012 | 0.0941M |
| December 31, 2011 | 5.208M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.955M
Minimum
Jun 2021
47.71M
Maximum
Dec 2022
21.35M
Average
6.250M
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 22.71M |
| Eli Lilly and Co | 51.05B |
| Cellectar Biosciences Inc | 13.43M |
| Outlook Therapeutics Inc | 46.03M |
| Bristol-Myers Squibb Co | 82.48B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 88.35M |
| Shareholders Equity (Quarterly) | 43.86M |